2m 2m 2m 2m 2m 2m 2m
ACTUATE THERAP (ACTU)
NASDAQ
$1.94+$0.01 (+0.52%)
Price as of Jun 24, 2026 5:22 AM EDT- $46.2MMarket Cap
- -71.41%1-Year Change
- BiotechnologyIndustry
ACTUATE THERAP (ACTU)
$1.94+$0.01 (+0.52%)
ACTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.93 | ||
Change | -$0.08 (-3.98%) | ||
Open | $1.97 | ||
High | $2.10 | ||
Low | $1.93 | ||
Previous Close | $2.01 | ||
Volume | 86,889 | ||
30-Day Average Volume | 167,173 | ||
1-Week Change | -4.93% | ||
1-Month Change | -18.91% | ||
1-Year Change | -71.41% | ||
3-Year Change | -61.40% | ||
5-Year Change | -61.40% | ||
Fundamentals | |||
Shares Outstanding | 23.9M | ||
Total Assets | $8.9M | ||
Market Cap | $46.2M | ||
Enterprise Value | $38.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$5.0M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $3.8M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -8 | ||
PEG | N/A | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue